{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:52:52Z","timestamp":1793962372561,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41401-019-0289-6","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T13:03:52Z","timestamp":1566306232000},"page":"229-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4\/TRAF6 and PLC\u03b31-Ca2+-NFATc1 signaling pathway"],"prefix":"10.1038","volume":"41","author":[{"given":"Xiang-zhou","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-hua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"key":"289_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","volume":"4","author":"C Zhao","year":"2006","unstructured":"Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006;4:111\u201321.","journal-title":"Cell Metab"},{"key":"289_CR2","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1128\/IAI.64.7.2371-2380.1996","volume":"64","author":"SP Nair","year":"1996","unstructured":"Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun. 1996;64:2371\u201380.","journal-title":"Infect Immun"},{"key":"289_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/jre.12252","volume":"50","author":"JAJ Keestra","year":"2014","unstructured":"Keestra JAJ, Grosjean I, Coucke W, Quirynen M, Teughels W. Non\u2010surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta\u2010analysis. J Periodontal Res. 2014;50:689\u2013706.","journal-title":"J Periodontal Res"},{"key":"289_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/SHK.0000000000000042","volume":"40","author":"JK Bohannon","year":"2013","unstructured":"Bohannon JK, Hernandez A, Enkhbaatar P, Adams WL, Sherwood ER. The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Shock. 2013;40:451\u201362.","journal-title":"Shock."},{"key":"289_CR5","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.4049\/jimmunol.172.4.2504","volume":"172","author":"K Suda","year":"2004","unstructured":"Suda K, Udagawa N, Sato N, Takami M, Itoh K, Woo JT, et al. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol. 2004;172:2504\u201310.","journal-title":"J Immunol"},{"key":"289_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbrc.2007.06.023","volume":"360","author":"S Islam","year":"2007","unstructured":"Islam S, Hassan F, Tumurkhuu G, Dagvadorj J, Koide N, Naiki Y, et al. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem Biophys Res Commun. 2007;360:346\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"289_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jcb.21167","volume":"101","author":"H Hotokezaka","year":"2006","unstructured":"Hotokezaka H, Sakai E, Ohara N, Hotokezaka Y, Gonzales C, Matsuo K, et al. Molecular analysis of RANKL\u2010independent cell fusion of osteoclast\u2010like cells induced by TNF\u2010\u03b1, lipopolysaccharide, or peptidoglycan. J Cell Biochem. 2006;101:122\u201334.","journal-title":"J Cell Biochem"},{"key":"289_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejphar.2016.03.014","volume":"779","author":"L He","year":"2016","unstructured":"He L, Duan H, Li X, Wang S, Zhang Y, Lei L, et al. Sinomenine down-regulates TLR4\/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis. Eur J Pharmacol. 2016;779:66\u201379.","journal-title":"Eur J Pharmacol"},{"key":"289_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2567.2010.03274.x","volume":"131","author":"II Khuda","year":"2010","unstructured":"Khuda II, Koide N, Noman AS, Dagvadorj J, Tumurkhuu G, Naiki Y, et al. Seladin\u20101 is a novel lipopolysaccharide (LPS)\u2010responsive gene and inhibits the tumour necrosis factor-\u03b1 production and osteoclast formation in response to LPS. Immunology. 2010;131:59\u201366.","journal-title":"Immunology."},{"key":"289_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000339052","volume":"30","author":"C Guo","year":"2012","unstructured":"Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, et al. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cell Physiol Biochem. 2012;30:123\u201336.","journal-title":"Cell Physiol Biochem"},{"key":"289_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3892\/ijmm.2013.1406","volume":"32","author":"GQ Hou","year":"2013","unstructured":"Hou GQ, Guo C, Song GH, Fang N, Fan WJ, Chen XD, et al. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells. Int J Mol Med. 2013;32:503\u201310.","journal-title":"Int J Mol Med"},{"key":"289_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/ars.2013.5748","volume":"22","author":"H Park","year":"2015","unstructured":"Park H, Noh AL, Kang JH, Sim JS, Lee DS, Yim M. Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3. Antioxid Redox Signal. 2015;22:63\u201377.","journal-title":"Antioxid Redox Signal"},{"key":"289_CR13","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1056\/NEJMct0709050","volume":"358","author":"PJ Rosenthal","year":"2008","unstructured":"Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N Engl J Med. 2008;358:1829\u201336.","journal-title":"N Engl J Med."},{"key":"289_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","volume":"142","author":"WE Ho","year":"2014","unstructured":"Ho WE, Peh HY, Chan TK, Wong WS. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther. 2014;142:126\u201339.","journal-title":"Pharmacol Ther"},{"key":"289_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.biopha.2017.10.018","volume":"96","author":"C Zhao","year":"2017","unstructured":"Zhao C, Liu Q, Wang K. Artesunate attenuates ACLT-induced osteoarthritis by suppressing osteoclastogenesis and aberrant angiogenesis. Biomed Pharmacother. 2017;96:410\u20136.","journal-title":"Biomed Pharmacother"},{"key":"289_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bcp.2016.10.007","volume":"124","author":"X Zeng","year":"2017","unstructured":"Zeng X, Zhang Y, Wang S, Wang K, Tao L, Zou M, et al. Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLC\u03b31-Ca2+\u2013NFATc1 signaling pathway and prevents ovariectomy-induced bone loss. Biochem Pharmacol. 2017;124:57\u201368.","journal-title":"Biochem Pharmacol"},{"key":"289_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jcp.25907","volume":"233","author":"CM Wei","year":"2017","unstructured":"Wei CM, Liu Q, Song FM, Lin XX, Su YJ, Xu J, et al. Artesunate inhibits RANKL\u2010induced osteoclastogenesis and bone resorption in vitro and prevents LPS\u2010induced bone loss in vivo. J Cell Physiol. 2017;233:476\u201385.","journal-title":"J Cell Physiol"},{"key":"289_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.phrs.2015.05.006","volume":"99","author":"D Thummuri","year":"2015","unstructured":"Thummuri D, Jeengar MK, Shrivastava S, Nemani H, Ramavat RN, Chaudhari P, et al. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-\u03baB and MAPK Signalling. Pharmacol Res. 2015;99:63\u201373.","journal-title":"Pharmacol Res"},{"key":"289_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337\u201342.","journal-title":"Nature"},{"key":"289_CR20","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.3892\/mmr.2017.7338","volume":"16","author":"F Ye","year":"2017","unstructured":"Ye F, Zhou Q, Tian L, Lei F, Feng D. The protective effect of berberine hydrochloride on LPS\u2011induced osteoclastogenesis through inhibiting TRAF6\u2011Ca2+\u2011calcineurin\u2011NFATc1 signaling pathway. Mol Med Rep. 2017;16:6228\u201333.","journal-title":"Mol Med Rep"},{"key":"289_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.febslet.2009.03.005","volume":"583","author":"SH Yoon","year":"2009","unstructured":"Yoon SH, Lee Y, Kim HJ, Lee ZH, Hyung SW, Lee SW, et al. Lyn inhibits osteoclast differentiation by interfering with PLCgamma1-mediated Ca2+ signaling. FEBS Lett. 2009;583:1164\u201370.","journal-title":"FEBS Lett"},{"key":"289_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10753-015-0236-8","volume":"39","author":"A He","year":"2016","unstructured":"He A, Ji R, Shao J, He C, Jin M, Xu Y. TLR4-MyD88-TRAF6-TAK1 complex-mediated NF-kappaB activation contribute to the anti-inflammatory effect of V8 in LPS-induced human cervical cancer SiHacells. Inflammation. 2016;39:172\u201381.","journal-title":"Inflammation"},{"key":"289_CR23","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","volume":"289","author":"GA Rodan","year":"2000","unstructured":"Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289:1508\u201314.","journal-title":"Science."},{"key":"289_CR24","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1248\/bpb.b16-00522","volume":"39","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Yan M, Yu QF, Yang PF, Zhang HD, Sun YH, et al. Puerarin prevents LPS-induced osteoclast formation and bone loss via inhibition of Akt activation. Biol Pharm Bull. 2016;39:2028\u201335.","journal-title":"Biol Pharm Bull"},{"key":"289_CR25","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1172\/JCI119679","volume":"100","author":"Y Abu-Amer","year":"1997","unstructured":"Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Investig. 1997;100:1557\u201365.","journal-title":"J Clin Investig."},{"key":"289_CR26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3:889\u2013901.","journal-title":"Dev Cell"},{"key":"289_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/jbmr.2771","volume":"31","author":"L Zhou","year":"2016","unstructured":"Zhou L, Liu Q, Yang M, Wang T, Yao J, Cheng J, et al. Dihydroartemisinin, an anti\u2010malaria drug, suppresses estrogen deficiency\u2010induced osteoporosis, osteoclast formation, and RANKL\u2010induced signaling pathways. J Bone Miner Res. 2016;31:964\u201374.","journal-title":"J Bone Miner Res"},{"key":"289_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007;40:251\u201364.","journal-title":"Bone."},{"key":"289_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.intimp.2016.06.007","volume":"38","author":"Y Cen","year":"2016","unstructured":"Cen Y, Liu C, Li X, Yan Z, Kuang M, Su Y, et al. Artesunate ameliorates severe acute pancreatitis (SAP) in rats by inhibiting expression of pro-inflammatory cytokines and Toll-like receptor 4. Int Immunopharmacol. 2016;38:252\u201360.","journal-title":"Int Immunopharmacol"},{"key":"289_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s11655-016-2650-7","volume":"23","author":"M Yang","year":"2017","unstructured":"Yang M, Guo MY, Luo Y, Yun MD, Yan J, Liu T, et al. Effect of Artemisia annua extract on treating active rheumatoid arthritis: a randomized controlled trial. Chin J Integr Med. 2017;23:496\u2013503.","journal-title":"Chin J Integr Med"},{"key":"289_CR31","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/ar3385","volume":"13","author":"EY Lee","year":"2011","unstructured":"Lee EY, Seo M, Juhnn YS, Kim JY, Hong YJ, Lee YJ, et al. Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis. Arthritis Res Ther. 2011;13:R104.","journal-title":"Arthritis Res Ther"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0289-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T06:55:36Z","timestamp":1721631336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0289-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0289-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"6 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}